Skip to main content
Full access
Letters
Published Online: 1 October 2013

Adult-Onset Psychosis and Clinical Genetics: A Case of Phelan-McDermid Syndrome

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Psychiatric presentation of Phelan-McDermid Syndrome (22q13.3 deletion) is not well characterized.1 We present the case of a patient whose worsening symptoms led to psychiatric evaluation, with subsequent genetic testing and diagnosis.

Case Report

The patient is a 38-year-old woman previously diagnosed with cerebral palsy, major depressive disorder with psychotic features, general anxiety disorder, and schizophrenia with catatonia. She has a history of developmental delay, hypotonia, and seizure-like activity since childhood. Although she has moderate mental retardation (IQ: 51) she is verbal, friendly, and completed high school (special education). General functioning, mood, and behavior were stable into adulthood until her first psychiatric hospitalization at age 32. She began having behavioral regression and decline in skills including bathing, dressing, and feeding. For periods of weeks she became nonverbal, confused, detached, and incontinent. She would often stare at her hands, at times shaking or screaming, and refuse to eat.
Dysmorphology examination was notable for multiple anomalies, including striking bilateral lateral eyelid fullness and ptosis. Chromosomal microarray revealed a 22q13.33 deletion diagnostic for Phelan-McDermid syndrome (OMIM#606232). Treatment was optimized with quetiapine titrated to 300 mg twice daily. Approximately 2 weeks after treatment initiation, her family reported significant improvements in the patient’s affect, speech, and level of independence, with resolution of psychotic symptoms and normalization of sleep/wake cycle. At 10 months later, she continues to struggle with depression, although her psychosis is improved.

Discussion

Patients with 22q13 deletion are haplo-insufficient for the SHANK3/PROSAP2 protein affecting excitatory synapse formation.2 Affected children often display stereotyped repetitive movements and struggle with sleep and socialization. Some are diagnosed with autistic spectrum disorder. Adults may develop psychotic symptoms, including catatonia.3 Our patient’s symptoms responded poorly to SSRI or benzodiazepine monotherapy, but relatively quickly to quetiapine. One previous case report showed a similar response to risperidone,2 and, together, these cases may build evidence for new approaches to treatment of these catatonic episodes specific to SHANK3 deletion.
Although a constellation of findings—facial gestalt, hypotonia, developmental and speech delay—are consistently seen in this syndrome, no clinical criteria are diagnostic; therefore, genetic testing is necessary. Caveats to genetic testing in psychiatry exist,3 but attention to behavioral regression, unexplained developmental delay, or unusual physical exam findings should prompt genetics consultation.
This case highlights the emerging role of genetic testing in psychiatry. This patient and her family now have an explanation for her lifelong diagnostic odyssey and valuable information regarding recurrence risk. A plan to screening for known medical comorbidities has been implemented, and the family has access to peer groups.4 Molecular evaluation in other people with similar presentation may lead to improved treatment strategies.

References

1.
Phelan K, McDermid HE: The 22q13.3 deletion syndrome (Phelan-McDermid syndrome) Mol Syndromol 2011
2.
Pasini A, D’Agati E, Casarelli L, et al.: Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome. Brain Dev 2010; 32:425–427
3.
Smith JH, Smith VD, Philbrick KL, et al.: Catatonic disorder due to a general medical or psychiatric condition. J Neuropsychiatry Clin Neurosci 2012; 24:198–207
4.
Braff DL, Freedman R: Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon. Am J Psychiatry 2008; 165:952–955

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E27
PubMed: 24247879

History

Published online: 1 October 2013
Published in print: Fall 2013

Authors

Affiliations

Erick Messias, M.D.
Dept. of Psychiatry, Medical College of GeorgiaGrovetown, GA
Sean N. Kaley, M.D.
Dept. of Psychiatry, University of Arkansas for Medical SciencesLittle Rock, AR
Kent D. McKelvey, M.D.
Dept. of Genetics, University of Arkansas for Medical SciencesLittle Rock, AR

Notes

Correspondence: e-mail: [email protected]

Funding Information

This project was supported by grants from the National Center for Research Resources (5P20RR020146-09), the National Institute of General Medical Sciences (8 P20 GM103425-09), the National Institutes of Health, and a CTSA award to the TRI (UL1 TR000039).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share